Vista Pharmaceuticals receives warning letter from USFDA for Telangana facility

13 Jul 2017 Evaluate

Vista Pharmaceuticals has received a warning letter from the US Food & Drug Administration (USFDA) for significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals at its formulation plant located at Nalgonda district in Telangana. The US regulator had inspected the said plant from September 19 to 23, 2016 and issued Form 483 observations.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.



Vista Pharma Share Price

14.45 0.68 (4.94%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.